Camarda Financial Advisors, LLC Biogen Inc. Transaction History

Camarda Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $2,174 - $2,438	-10 Closed	0 $0
Q1 2019 Apr 25, 2019	BUY	$216.71 - $338.96 $2,167 - $3,389	10 New	10 $2,000
Q4 2018 Jan 23, 2019	SELL	$278.5 - $352.75 $830,765 - $1.05 Million	-2,983 Closed	0 $0
Q3 2018 Oct 31, 2018	SELL	$293.51 - $383.83 $23,774 - $31,090	-81 Reduced 2.64%	2,983 $1.05 Million
Q2 2018 Jul 31, 2018	BUY	$257.52 - $306.91 $789,041 - $940,372	3,064 New	3,064 $889,000

1,049

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $26.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Camarda Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Camarda Financial Advisors, LLC with notifications on news.